You are viewing: China Diagnostic Imaging Market analysis
Part of: Diagnostic Imaging Market (Global)

The China Diagnostic Imaging Market was valued at $2335.9 Million in 2025 and projected to reach to $2979.7 Million by 2030, representing a compound annual growth rate of 5.0%. China's diagnostic imaging market is poised for sustained expansion, supported by government healthcare reforms and increased per capita healthcare expenditure.

China Diagnostic Imaging Market Trends and Insights

  • This 5.0% compound annual growth rate reflects China's accelerating healthcare infrastructure investments and rising demand for advanced imaging technologies across urban and emerging markets.
  • China's aging population and increasing prevalence of chronic diseases are driving adoption of CT, MRI, ultrasound, and digital radiography systems. The diagnostic imaging sector in China benefits from government healthcare reforms, expanded insurance coverage, and modernization of hospital facilities.
  • China's emphasis on early disease detection and preventive care is spurring capital equipment purchases and service demand.
  • Major cities and secondary markets in China are upgrading imaging capabilities, while rural healthcare initiatives are extending access to diagnostic services. China's competitive landscape includes both multinational equipment manufacturers and domestic players capturing market share.
  • Technological innovation, cost-effective solutions, and regulatory support position China as a high-growth market within the Asia Pacific region through 2030..

Key Market Statistics

  • CAGR (2025-2030) 5.0% CAGR
  • Market Size, 2025 ~USD 2335.9 Million
  • Forecast, 2030 ~USD 2979.7 Million
  • Country China

China Diagnostic Imaging Market Overview

Market Valuation Growth :

China's diagnostic imaging market is valued at USD 2,335.9 million in 2025, with projections reaching USD 2,979.7 million by 2030, representing a robust 5.0% CAGR driven by healthcare modernization initiatives.

Aging Population Impact :

China's rapidly aging demographic is significantly increasing demand for diagnostic imaging services, as chronic diseases and age-related conditions require advanced imaging for early detection and treatment planning.

Healthcare Infrastructure Expansion :

Substantial government investments in healthcare infrastructure across urban and rural regions are accelerating adoption of advanced imaging technologies, including CT, MRI, and ultrasound systems.

Technology Adoption Acceleration :

Rising healthcare spending and increasing prevalence of lifestyle diseases in China are driving demand for cutting-edge diagnostic imaging solutions, positioning the market for sustained growth through 2030.

China Diagnostic Imaging Market Dynamics

  • The 5.0% CAGR reflects strong demand from both urban centers and emerging secondary cities, where healthcare infrastructure development is accelerating.
  • Rising awareness of preventive healthcare and early disease detection is driving adoption of advanced imaging modalities. The market outlook remains positive through 2030, with key growth drivers including China's aging population, urbanization trends, and technological advancement in imaging equipment.
  • Strategic investments by both domestic and international players, coupled with regulatory support for healthcare modernization, will continue to fuel market expansion and create significant opportunities for diagnostic imaging providers and technology innovators..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Stryker Corporation
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • China's diagnostic imaging market will grow from USD 2,335.9M (2025) to USD 2,979.7M (2030) at a 5.0% CAGR.
      • China's aging demographics and rising chronic disease burden are primary drivers of imaging equipment and service demand.
      • Government healthcare reforms and expanded insurance coverage in China are accelerating hospital modernization and imaging adoption.
      • China's mix of multinational and domestic manufacturers creates competitive pricing and innovation opportunities across the market.

      Diagnostic Imaging Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ULTRA-HIGH-FIELD (Field Strength)
      Forecast Period 2025–2030
      Growth Rate CAGR of 4.4% from 2025 to 2030
      Largest Segment HOSPITALS (End User)
      Market Size Base Year (Billions) ~USD 26.53 (2025)
      Revenue Forecast (Billions) ~USD 32.9 (2030)
      Segments Covered Application, Modality, Type, Technology, Portability, Architecture, Field Strength, End User

      China Diagnostic Imaging Market Report Segmentation

      8 segment dimensions are covered across the global market.

      By Application

      • Brain & Neurological Mri
      • Breast Mri
      • Cardiac Mri
      • Cardiology
      • Dentistry
      • Fluoroscopy
      • General Radiography
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Other Applications
      • Pelvic & Abdominal Mri
      • Radiology/General Imaging
      • Spine & Musculoskeletal Mri
      • Urology
      • Vascular
      • Vascular Mri

      By Modality

      • Ct Scanners
      • Mammography Systems
      • Mri Systems
      • Nuclear Imaging Systems
      • Ultrasound
      • Ultrasound Systems
      • X-Ray Imaging Systems

      By Type

      • Analog
      • Analog X-Ray Imaging Systems
      • Cone-Beam
      • Conventional
      • Conventional Ct
      • Digital
      • Digital X-Ray Imaging Systems
      • High-Slice
      • Hybrid Spect
      • Hybrid Spect Systems
      • Low-Slice
      • Mid-Slice
      • Pet
      • Pet Systems
      • Spect
      • Spect Systems

      By Technology

      • 2D
      • 2D Ultrasound
      • 3D & 4D
      • 3D And 4D Ultrasound
      • Contrast-Enhanced
      • Contrast-Enhanced Ultrasound Systems
      • Doppler Imaging
      • Doppler Imaging Systems

      By Portability

      • Compact/Portable
      • Portable
      • Portable X-Ray
      • Stationary
      • Stationary X-Ray
      • Trolley/Cart-Based

      By Architecture

      • Closed
      • Open

      By Field Strength

      • High & Very High-Field
      • High And Very-High-Field
      • Low-To-Mid-Field
      • Ultra-High-Field

      By End User

      • Diagnostic Imaging Centers
      • Hospitals
      • Other End Users

      Target Audience

      • Medical Device Manufacturers : Diagnostic imaging equipment manufacturers need China-specific market data to assess market size, growth potential, and competitive opportunities for CT, MRI, ultrasound, and other imaging technologies.
      • Healthcare Investors & PE Firms : Investment professionals require detailed China market analysis to evaluate investment opportunities in diagnostic imaging providers, technology companies, and healthcare infrastructure projects with clear growth trajectories.
      • Hospital & Imaging Center Operators : Healthcare facility operators need market insights to guide capital expenditure decisions, technology upgrades, and service expansion strategies aligned with China's growing diagnostic imaging demand.
      • Healthcare Consultants & Advisors : Consulting firms advising healthcare clients require comprehensive China market data to develop strategic recommendations, competitive analyses, and market entry strategies for diagnostic imaging services.
      • Government & Policy Makers : Healthcare policy officials and government agencies need market intelligence to inform healthcare infrastructure planning, technology adoption initiatives, and regulatory frameworks supporting diagnostic imaging sector growth.

      Key Companies in the China Diagnostic Imaging Market

      CompanyHQOwnershipStrongest segments
      TOSHIBA CORPORATIONJapanPrivate CompanyEnergy Systems & Solutions,Infrastructure Systems & Solutions,Electronic Devices and Storage Solutions,
      AT&SCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation lifecycle services,Contract manufacturing and integration services,
      HEALTHFUSION INC.United StatesPrivate CompanyMediTouch EHR (clinical module),Practice Management & Scheduling,Clearinghouse & Revenue Cycle Transactions,
      UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
      UNITED IMAGING HEALTHCARE CO., LTD.ChinaPublic CompanyMagnetic Resonance Imaging,Computed Tomography,Molecular Imaging (PET/CT, SPECT),
      SIEMENS HEALTHINEERSGermanyPublic Company
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems and Devices,Monitoring and Enterprise Informatics,
      FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductors, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document services, graphic communications, inkjet),
      CANONJapanPublic CompanyPrinting Business Unit (office, production, large-format, document solutions),Imaging Business Unit (cameras, lenses, network cameras, cinema/broadcast),Medical Business Unit (diagnostic imaging, ophthalmology, IVD, healthcare IT),
      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring, anesthesia, ventilators, and defibrillation,Ultrasound and radiology imaging,In-vitro diagnostics (CLIA, chemistry, hematology),
      ESAOTE S.P.AItalyPrivate CompanyUltrasound diagnostic imaging systems,Dedicated MRI systems (MSK, weight-bearing, head),Healthcare IT software (radiology, cardiology, oncology),
      SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems (Imaging and Fluorescence),Industrial and Vacuum Machinery,
      HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Panther/Aptima and related assays),Breast Health (3D mammography, biopsy, imaging software, service),GYN Surgical (MyoSure, NovaSure, Acessa, Fluent, CoolSeal),
      AGFA-GEVAERT GROUPBelgiumPublic CompanyHealthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray film, and hardcopy,Sign and display and packaging printers, inks, and software,
      CURVEBEAM AI, LTD.United StatesPublic CompanyLower extremity weight-bearing CT (LineUP, pedCAT, pedCAT Premium, TALAS, Autometrics, Axiometrics),HiRise bilateral weight-bearing CT (multi-joint, including hip and full lower limb),Upper extremity and general point-of-care CT (InReach, OSSView, CubeVue, custom cloud platforms),

      TOSHIBA CORPORATION

      Toshiba Corporation is a private company founded in 1875 and based in Japan with 106,648 employees.

      AT&S

      AT&S is a public company founded in 1978 and based in Canada with 7,000 employees.

      HEALTHFUSION INC.

      HealthFusion Inc. is a private company founded in 1998 and based in the United States with 120 employees.

      UNILABS

      Unilabs is a private company founded in 1987 and based in Switzerland with 1,897 employees.

      UNITED IMAGING HEALTHCARE CO., LTD.

      United Imaging Healthcare Co., Ltd. is a public company founded in 2011 and based in China with 8,703 employees.

      SIEMENS HEALTHINEERS

      Siemens Healthineers is a public company founded in 1896 and based in Germany with 72,369 employees.

      GE HEALTHCARE

      GE Healthcare is a public company founded in 2022 and based in the United States with 54,000 employees.

      KONINKLIJKE PHILIPS N.V.

      Koninklijke Philips N.V. is a public company founded in 1891 and based in the Netherlands with 64,317 employees.

      FUJIFILM CORPORATION

      Fujifilm Corporation is a public company founded in 1934 and based in Japan with 73,526 employees.

      CANON

      Canon is a public company founded in 1933 and based in Japan with 165,547 employees.

      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

      Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a public company founded in 1991 and based in China with 21,288 employees.

      ESAOTE S.P.A

      Esaote S.p.A. is a private company founded in 1982 and based in Italy with 1,067 employees.

      SHIMADZU CORPORATION

      Shimadzu Corporation is a public company founded in 1875 and based in Japan with 14,649 employees.

      HOLOGIC, INC.

      Hologic, Inc. is a private company founded in 1985 and based in the United States with 7,070 employees.

      AGFA-GEVAERT GROUP

      Agfa-Gevaert Group is a public company founded in 1867 and based in Belgium with 4,211 employees.

      CURVEBEAM AI, LTD.

      CurveBeam AI, Ltd. is a public company founded in 2009 and based in the United States with 50 employees.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for China's diagnostic imaging sector with verified 5.0% CAGR projections through 2030, enabling accurate business planning and investment decisions in this high-growth market.
      • Competitive Positioning Intelligence : Understand China-specific market dynamics, regional variations, and competitive landscape to identify opportunities for market entry, expansion, or strategic partnerships within the diagnostic imaging sector.
      • Demographic & Demand Insights : Access detailed analysis of China's aging population trends and their impact on diagnostic imaging demand, helping stakeholders align product development and marketing strategies with evolving healthcare needs.
      • Investment & Expansion Strategy : Leverage comprehensive China market data to support investment decisions, facility planning, and resource allocation for diagnostic imaging providers, manufacturers, and healthcare technology companies.
      • Regulatory & Infrastructure Context : Gain insights into China's healthcare infrastructure investments and government initiatives driving diagnostic imaging adoption, essential for understanding market barriers, opportunities, and long-term growth potential.

      Frequently asked questions

      What is the current size of China's diagnostic imaging market?

      China's diagnostic imaging market is valued at USD 2,335.9 million in 2025 and is expected to reach USD 2,979.7 million by 2030.

      What is the projected growth rate for diagnostic imaging in China?

      China's diagnostic imaging market is projected to grow at a compound annual growth rate (CAGR) of 5.0% from 2025 to 2030.

      What factors are driving growth in China's diagnostic imaging market?

      Key drivers include China's aging population, rising prevalence of chronic diseases, government healthcare reforms, expanded insurance coverage, and modernization of hospital facilities.

      Which imaging modalities are most in demand in China?

      CT, MRI, ultrasound, and digital radiography systems are among the most demanded imaging modalities in China due to their diagnostic capabilities and clinical applications.

      Who are the major players in China's diagnostic imaging market?

      China's diagnostic imaging market includes multinational equipment manufacturers and domestic players, with competition driven by technological innovation and cost-effective solutions.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the diagnostic imaging market. Exhaustive secondary research was done to collect information on the peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial diagnostic imaging market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the diagnostic imaging market. The primary sources from the demand side include medical OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

      A breakdown of the primary respondents is provided below:

      Diagnostic Imaging Market

      Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 2: D-level executives include directors of operations, directors of finance, directors of marketing, and directors of product management

      Note 3: C-level executives include chief executive officers, chief financial officers, chief operating officers, and chief marketing officers.

      Note 4: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      In this report, the size of the diagnostic imaging market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included studying the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

      Segmental revenues were calculated based on the revenue mapping of major product providers to calculate the global market value. This process involves the following steps:

      • Generating a list of major global players operating in the diagnostic imaging market
      • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
      • Mapping the revenues of major players to cover a major share of the global market, as of 2024
      • Extrapolating the global value of the diagnostic imaging market industry
      Diagnostic Imaging Market

      Data Triangulation

      After arriving at the overall market size from the market size estimation process explained above, the global diagnostic imaging market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the diagnostic imaging market was validated using top-down and bottom-up approaches.

      Market Definition

      Diagnostic imaging involves the use of various diagnostic modalities to visualize a patient’s anatomy. This market addresses the industry focusing on various technologies used for the detection, monitoring, and diagnosis of different medical conditions. Different imaging modalities include computed tomography (CT), ultrasound, X-ray imaging, MRI, nuclear imaging, and mammography technologies. These modalities help healthcare professionals to visualize the internal structure and other surrounding tissues. Diagnostic imaging equipment is primarily used in hospitals, diagnostic imaging centers, and ambulatory imaging centers.

      Stakeholders

      • Senior Management
      • End Users
      • R&D Department
      • Finance/Procurement Department

      Report Objectives

      • To define, describe, and forecast the size of the diagnostic imaging market based on modality, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth potential of the global diagnostic imaging market (drivers, restraints, opportunities, challenges, and trends)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global diagnostic imaging market
      • To analyze key growth opportunities in the global diagnostic imaging market for key stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa
      • To profile the key players in the diagnostic imaging market and comprehensively analyze their market shares and core competencies
      • To track and analyze the competitive developments undertaken in the global diagnostic imaging market, such as product launches, agreements, expansions, alliances, and mergers & acquisitions

       

      Get the Full Diagnostic Imaging Market Report

      Full forecast, segment splits, and company analysis for all Diagnostic Imaging Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status